secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001477449-25-000117
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Q3 revenue down 2% to $626.4M; net loss widens to $49.5M; adj. EBITDA falls 16%
--------------------------------------------------------------------------------

- Revenue $626.4M (-2% YoY); net loss $49.5M ($0.28 per share) vs. $33.3M loss a year ago.
- Adjusted EBITDA $69.9M (-16% YoY); Integrated Care segment rev +2% to $389.5M; BetterHelp rev -8% to $236.9M.
- Full-year 2025 guidance: revenue $2.51B-$2.539B; adj. EBITDA $270M-$287M; net loss per share ($1.25)-($1.10).
- Cash from ops $99.3M in Q3; free cash flow $67.9M vs. $79.0M a year ago.
- Non-cash goodwill impairment of $12.6M in Q3; $17.0M stock-based comp; $85.8M amortization intangibles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744925000117/0001477449-25-000117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744925000117/tdoc-20251029.htm
  HTML page:      https://secwatch.observer/filing/0001477449-25-000117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer